Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 June 2025 to Question 56598 on Restless Legs Syndrome: Medical Treatments, whether he plans to make such an assessment.

The Department has no plans to make such an assessment. The National Institute for Health and Care Excellence (NICE) has an established prioritisation process overseen by a prioritisation board, for the identification of priorities for guidance development. Anyone is able to suggest a topic through the NICE website, at the following link:

https://www.nice.org.uk/forms/topic-suggestion

The licensed dopamine agonist medicines that are indicated for the treatment of restless leg syndrome are ropinirole, pramipexole, and rotigotine. Decisions about what medicines to prescribe are made by healthcare professionals and National Health Service commissioners, based on an assessment of the available evidence, taking into account national guidance and advice, such as Clinical Knowledge Summaries.